A Pharmacometric Workflow for Resolving Model Instability in Model Use‐Reuse Settings

The development of fit-for-purpose pharmacokinetic-pharmacodynamic (PKPD) models based on clinical and pre-clinical data is a critically important process in model informed drug development. This process is often hampered by modeling stability issues that are often multifactorial in nature and difficult to overcome, leading to protracted model building and arbitrary simplification of the model. This tutorial provides a heuristic workflow to help identify and resolve issues relating to model instability. The approach is centered on analyses undertaken using NONMEM, but the concepts can be generalized to other software used for population analysis of pharmacokinetics (PK) or PKPD data.

Authors

Institutions

Publication Details

Journal
CPT Pharmacometrics & Systems Pharmacology
Published
2025-06-27
DOI
https://doi.org/10.1002/psp4.70049
Citations
3
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
4.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Pharmacometric Workflow for Resolving Model Instability in Model Use‐Reuse Settings

Hailemichael Zeru Hishe, Ahmed Aliyu Abulfathi, Stephen B. Duffull, Xiao Zhu et al.
3 citations
CPT Pharmacometrics & Systems Pharmacology
Pharmacogenetics and Drug Metabolism
4.67
article

A Pharmacometric Workflow for Resolving Model Instability in Model Use‐Reuse Settings

Hailemichael Zeru Hishe, Ahmed Aliyu Abulfathi, Stephen B. Duffull, Xiao Zhu, Daniel F. B. Wright, Xin Liu
article en
3 citations

Abstract

The development of fit-for-purpose pharmacokinetic-pharmacodynamic (PKPD) models based on clinical and pre-clinical data is a critically important process in model informed drug development. This process is often hampered by modeling stability issues that are often multifactorial in nature and difficult to overcome, leading to protracted model building and arbitrary simplification of the model. This tutorial provides a heuristic workflow to help identify and resolve issues relating to model instability. The approach is centered on analyses undertaken using NONMEM, but the concepts can be generalized to other software used for population analysis of pharmacokinetics (PK) or PKPD data.

CPT Pharmacometrics & Systems PharmacologyVol. 14(10)
The University of Sydney (AU), Fudan University (CN), St Vincent's Hospital Melbourne (AU), St Vincent's Hospital Sydney (AU), Certara (United States) (US), St Vincent's Clinic (AU), Integra LifeSciences (United States) (US)
Openalex Percentile: Top 6%
Pharmacogenetics and Drug Metabolism
4.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.